Physician profile
Harry J Mccarty
NPI 1265550131
$6,268.04
in general payments reported to CMS, 2019-2025
10 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $593 · 2020: $184 · 2021: $174 · 2022: $2,987 · 2023: $2,052 · 2024: $65.07 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,442 · Travel and Lodging: $887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,441.97 |
| Travel and Lodging | $887.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $3,705.99 | 2021-2025 | Truebeam, Halcyon, Varian Treatment |
| Brainlab, INC. | $1,626.08 | 2019-2023 | Image Guided Surgical Device |
| Varian Medical Systems, INC. | $447.00 | 2019-2020 | |
| Novocure INC. | $222.19 | 2020-2025 | Optune |
| Sumitomo Pharma America, INC. | $125.06 | 2023 | Orgovyx |
| Eisai INC. | $64.37 | 2019-2022 | |
| Pharmacyclics LLC, An Abbvie Company | $23.64 | 2019-2020 | |
| Boston Scientific Corporation | $21.75 | 2023 | Spaceoar Vue System - 10ml |
| Merck Sharp & Dohme LLC | $18.35 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Mccarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.